When a new cancer drug shows promise, it trends globally. When a gene therapy corrects a rare mutation, headlines follow. But when a novel antibiotic advances against drug-resistant pathogens — silence. That silence is dangerous. The World Health Organization has repeatedly warned that antimicrobial resistance (AMR) is among the top global public health threats. Resistant…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
